News

There's growth beyond AI.

There's more than one path to reach your goals.

When it comes to generating hype and buzz, there's still no better meme coin than Dogecoin.

SPDR Gold Shares and iShares Gold Trust have many similarities and one glaring difference.

Three blue-chip Canadian stocks could give you an ETF-like foundation, with dividends and long-term staying power.

The Vanguard FTSE Canadian High Dividend Yield Index ETF (TSX:VDY) can contribute income to your TFSA.

This AI stock has a market cap below $1 billion and is starting to rev up.

One Vanguard fund pairs an extremely low fee with deep exposure to America's most dominant companies -- and the long-term track record to match.

This ETF combines low-volatility Canadian stocks with a options-based yield overlay.

The healthcare sector outperformed the rest of the market over the past week.

Growth, income, and defensive investors can find utility with these Canadian ETF picks.

Should you follow the old Wall Street saying, "Sell in May and go away"?

The Vanguard Core Plus Bond Fund focuses on active fixed income strategies, combining investment-grade bonds with selective high-yield allocations.

JEMA offers actively managed exposure to emerging market equities.

The Goldman Sachs S&P 500 Premium Income ETF targets steady income and equity exposure through an options-based strategy for U.S. investors.

SpaceX IPO excitement took the NASA ETF past $1bn in AUM just 37 days after launch. CEO Maurits Pot says space economy is "still in early innings."

As Lam Research has outperformed the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.

Polen Capital launched the PCLC and PCSG active ETFs targeting AI, aerospace, genomics and electrification trends as demand for actively managed growth funds accelerates.

Citi says another rally in Sandisk stock is imminent.

While BXP has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Ripple USD could become a good substitute for real U.S. dollars.

Cboe Global Markets has considerably outperformed the broader market over the past 52 weeks, yet Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Although VeriSign has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Compare how these two S&P 500 giants stack up on long-term returns, dividend yields, and fund size beyond their headline expense ratios.